Hanke CW - Search Results

1

Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: results of two placebo-controlled studies of daily application to the face and balding scalp for two 3-week cycles.

Hanke CW, Beer KR, Stockfleth E, Wu J, Rosen T, Levy S. Hanke CW, et al. J Am Acad Dermatol. 2010 Apr;62(4):573-81. doi: 10.1016/j.jaad.2009.06.020. Epub 2010 Feb 4. J Am Acad Dermatol. 2010. PMID: 20133012 Clinical Trial.

2

Complete clearance is sustained for at least 12 months after treatment of actinic keratoses of the face or balding scalp via daily dosing with imiquimod 3.75% or 2.5% cream.

Hanke CW, Swanson N, Bruce S, Berman B, Kulp J, Levy S. Hanke CW, et al. J Drugs Dermatol. 2011 Feb;10(2):165-70. J Drugs Dermatol. 2011. PMID: 21283921 Clinical Trial.

3

Efficacy and safety of ingenol mebutate gel in field treatment of actinic keratosis on full face, balding scalp, or approximately 250 cm² on the chest: A phase 3 randomized controlled trial.

Hanke CW, Albrecht L, Skov T, Larsson T, Østerdal ML, Spelman L. Hanke CW, et al. J Am Acad Dermatol. 2020 Mar;82(3):642-650. doi: 10.1016/j.jaad.2019.07.083. Epub 2019 Jul 30. J Am Acad Dermatol. 2020. PMID: 31374304 Clinical Trial.

4

A seamless phase I/II dose-finding trial assessing ingenol disoxate (LEO 43204) for field treatment of actinic keratosis on the scalp.

Weiss J, Ulrich M, Bukhalo M, Østerdal ML, Bang B, Hanke CW. Weiss J, et al. Among authors: hanke cw. Br J Dermatol. 2017 Jun;176(6):1456-1464. doi: 10.1111/bjd.15304. Epub 2017 Apr 25. Br J Dermatol. 2017. PMID: 28078678 Clinical Trial.

5

Ingenol mebutate gel for actinic keratosis: the link between quality of life, treatment satisfaction, and clinical outcomes.

Augustin M, Tu JH, Knudsen KM, Erntoft S, Larsson T, Hanke CW. Augustin M, et al. Among authors: hanke cw. J Am Acad Dermatol. 2015 May;72(5):816-21. doi: 10.1016/j.jaad.2015.01.036. Epub 2015 Mar 11. J Am Acad Dermatol. 2015. PMID: 25770879 Clinical Trial.

6

Second intention healing for intermediate and large postsurgical defects of the lip.

Leonard AL, Hanke CW. Leonard AL, et al. Among authors: hanke cw. J Am Acad Dermatol. 2007 Nov;57(5):832-5. doi: 10.1016/j.jaad.2006.07.030. J Am Acad Dermatol. 2007. PMID: 17939934

7

Photodynamic diagnosis of tumor margins using methyl aminolevulinate before Mohs micrographic surgery.

Tierney E, Petersen J, Hanke CW. Tierney E, et al. Among authors: hanke cw. J Am Acad Dermatol. 2011 May;64(5):911-8. doi: 10.1016/j.jaad.2010.03.045. J Am Acad Dermatol. 2011. PMID: 21496702

8

Treatment of HIV lipoatrophy and lipoatrophy of aging with poly-L-lactic acid: a prospective 3-year follow-up study.

Levy RM, Redbord KP, Hanke CW. Levy RM, et al. Among authors: hanke cw. J Am Acad Dermatol. 2008 Dec;59(6):923-33. doi: 10.1016/j.jaad.2008.07.027. J Am Acad Dermatol. 2008. PMID: 19022099 Clinical Trial.

9

Response to 'Current status of surgery in dermatology'.

Hanke CW. Hanke CW. J Am Acad Dermatol. 2014 Aug;71(2):391. doi: 10.1016/j.jaad.2014.03.056. J Am Acad Dermatol. 2014. PMID: 25037789 No abstract available.

10

Efficacy and safety of ingenol disoxate gel in field treatment of actinic keratosis on full face, scalp or large area (250 cm2) on the chest: results of four phase 3 randomized controlled trials.

Berman B, Bukhalo M, Hanke CW, Jarner MF, Larsson T, Siegel DM, Skov T, Szeimies RM. Berman B, et al. Among authors: hanke cw. Dermatol Online J. 2020 Oct 15;26(10):13030/qt7677c8r4. Dermatol Online J. 2020. PMID: 33147665 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

253 results

Search Page

Filters